A MAGE-6-encoded peptide is recognized by expanded lymphocytes infiltrating a spontaneously regressing human primary melanoma lesion

European Journal of Immunology

Volumn 29, Issue 2, 1999, Pages 602-607

  Zorn, Emmanuel ^a,b   Hercend, Thierry ^a,c  

^a HÔPITAL PAUL BROUSSE   (France)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c Vertex Pharmaceuticals Ltd   (United Kingdom)

Author keywords

Immunosurveillance; MAGE; Regressive melanoma; Tumor antigen; Tumor infiltrating lymphocyte

Indexed keywords

TUMOR ANTIGEN;

ANIMAL CELL; ARTICLE; CANCER REGRESSION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; LYMPHOCYTIC INFILTRATION; MELANOMA; MULTIGENE FAMILY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE;

AGED; AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEOPLASM REGRESSION, SPONTANEOUS; SKIN NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032993152     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199902)29:02<602::AID-IMMU602>3.0.CO;2-Y     Document Type: Article

References (18)

1. Ferradini, L., Mackensen, A., Genevée, C., Bosq, J., Duvillard, P., Avril, M. F., and Hercend, T., Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. J. Clin. Invest. 1993. 91: 1183-1190.
2. Mackensen, A., Ferradini, L., Carcelain, G., Triebel, F., Faure, F., Viel, S. and Hercend, T., Evidence for in situ amplification of cytotoxic T-lymphocytes with anti-tumor activity in a human regressive melanoma. Cancer Res. 1993. 53: 3569-3573.
3. Mackensen, A., Carcelain, G., Viel, S., Raynal, M. C., Michalaki, H., Triebel, F., Bosq, J. and Hercend, T., Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J. Clin. Invest. 1994. 93: 1397-1402.
4. Zorn, E. and Hercend, T., A natural anti-tumor cytotoxic T cell response in a spontaneously regressing human melanoma targets a neoantigen resulting from a somatic point mutation. Eur. J. Immunol. 1999. 29: 592-601.
5. Van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A. and Boon, T., A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991. 254: 1643-1647.
6. De Plaen, E., Arden, K., Traversari, C., Gaforio, J. J., Szikora, J. P., De Smet, C., Brasseur, F., Van der Bruggen, P., Lethé, B., Lurquin, C., Brasseur, R., Chomez, P., De Backer, O., Cavenee, W. and Boon, T., Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 1994. 40: 360-369.
7. Patard, J. J., Brasseur, F., Gil-Diez, S., Radvanyi, F., Marchand, M., François, P., Abi-Aad, A., Van Cangh, P., Abbou, C. C., Chopin, D. and Boon, T., Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder. Int. J. Cancer 1995. 64: 60-64.
8. Ishida, H., Matsumura, T., Salgaller, M. L., Ohmizono, Y., Kadono, Y. and Sawada, T., MAGE-1 and MAGE-3 or -6 expression in neuroblastoma-related pediatric solid tumors. Int. J. Cancer 1996. 69: 375-380.
9. Gaugler, B., Van den Eynde, B., Van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethé, B., Brasseur, F. and Boon, T., Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 1994. 179: 921-930.
10. Traversari, C., Van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A. and Boon, T., A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med. 1992. 176: 1453-1457.
11. Van der Bruggen, P., Szikora, J. P., Boël, P., Wildmann, C., Somville, M., Sensi, M. and Boon. T., Autologous cytolytic T lymphocytes recognize MAGE-1 nonapeptide on melanoma expressing HLA-Cw1 601. Eur. J. Immunol. 1994. 24: 2134-2140.
12. Van der Bruggen, P., Bastin, J., Gajewsky, T., Coulie, P. G., Boël, P., De Smet, C., Traversari, C., Townsend, A. and Boon, T., A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol. 1994. 24: 3038-3043.
13. Herman, J., Van der Bruggen, P., Luescher, I. F., Mandruzzato, S., Romero, P., Thonnard, J., Fleischhauer, K., Boon, T. and Coulie, P., A peptide encoded by the human MAGE-3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Immunogenetics 1996. 43: 377-383.
14. Salgaller, M. L., Weber, J. S., Koenig, S., Yannelli, J. R. and Rosenberg, S. A., Generation of specific anti-melanoma reactivity by stimulation of tumor-infiltrating lymphocytes with MAGE-1 synthetic peptides. Cancer Immunol. Immunother. 1994. 39: 105-116.
15. Toso, J. F., Oei, C., Oshidari, F., Tartaglia, J., Paoletti, E., Lyerly, H. K., Talib, S. and Weinhold, K. J., MAGE-1 specific precursor cytotoxic T-lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: characterization and antigen specific activation. Cancer Res. 1996. 56: 16-20.
16. Carcelain G., Rouas-Freiss, N., Zorn, E., ChungScott, V., Viel, S., Faure, F., Bosq, J. and Hercend, T., In situ T-cell responses in a primary regressive melanoma and subsequent metastases: a comparative analysis. Int. J. Cancer 1997. 72: 241-247.
17. Strachan, T., Sodoyer, R., Damotte, M. and Jordan, B. R., Complete nucleotide sequence of a functional class 1 HLA gene, HLA-A3: implications for the evolution of HLA genes. EMBO J. 1984. 3: 887-894.
18. Wang, R. F., Robbins, P. F., Kawakami, Y., Kang, X. Q. and Rosenberg, S. A., Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor infiltrating lymphocytes. J. Exp. Med. 1995. 181: 799-804.